Journal of Immunology Research / 2015 / Article / Tab 4

Research Article

Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Table 4

Aggregates content obtained by SE-UPLC. Variation is presented as confidence interval at 95% ( = 3).

ProductBatchAggregates (%)

MabTheraB622220.11 ± 0.01
H06050.07 ± 0.01
N35180.09 ± 0.02

Kikuzubam54451310150.13 ± 0.03
54451306080.10 ± 0.05
54451312160.25 ± 0.03

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.